Stay updated on Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedIntroduces a Show glossary control on the page. Makes minor textual changes to labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and updates the revision from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check40 days agoChange DetectedThe Locations section has been expanded to include numerous geographic sites across the United States, Canada, Australia, and Europe. The page layout has been reorganized to reflect these sites.SummaryDifference2%

- Check61 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check68 days agoChange DetectedA note was added to Publications clarifying that publications are provided voluntarily by the person entering study information and pertain to the study results, and the Revision label was updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check76 days agoChange DetectedTwo new trial locations in Tainan, Taiwan (postal codes 704 and 736) were added. The existing Tainan City entries for 704 and 736 were renamed to 'Tainan, Taiwan' with the same postal codes.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.